Literature DB >> 7958574

Patient characteristics associated with the labelling of asthma.

B Sibbald1, S Kerry, D P Strachan, H R Anderson.   

Abstract

Patient characteristics associated with the asthma label were investigated in 262 children, aged 8 years, who reported wheezing illness in the previous 12 months. Children were first identified by a screening questionnaire administered to the parents of all 8 year old schoolchildren in Croydon, south London. Interviews were conducted with those reported to have had a wheezing illness in the previous 12 months to obtain details of the child's illness, medical care, demographic and socioeconomic characteristics. Multivariate analysis showed that the likelihood of being labelled asthmatic was increased in those who had a parental history of hayfever [odds ratio (OR) = 2.24, 95% confidence interval (CI) = 1.22-4.14] or at least two allergic provoking factors (OR = 3.83, 95% CI = 1.44-10.15). No significant associations were found between asthma labelling and children's socioeconomic characteristics or use of general practitioner services. These findings suggest that wheeze is likely to be labelled asthma when the clinical history suggests an allergic aetiology.

Entities:  

Mesh:

Year:  1994        PMID: 7958574     DOI: 10.1093/fampra/11.2.127

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  2 in total

1.  Association of air pollution with daily GP consultations for asthma and other lower respiratory conditions in London.

Authors:  S Hajat; A Haines; S A Goubet; R W Atkinson; H R Anderson
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

2.  Identification of gaps in the diagnosis and treatment of childhood asthma using a community-based participatory research approach.

Authors:  Toby C Lewis; Thomas G Robins; Christine L M Joseph; Edith A Parker; Barbara A Israel; Zachary Rowe; Katherine K Edgren; Maria A Salinas; Michael E Martinez; Randall W Brown
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.